Nancy Lin, MD

home / authors / nancy-lin-md

Nancy Lin, MD, is a professor of medicine, Harvard Medical School, and medical oncologist, Harvard Cancer Institute, in Boston, Massachusetts.

Articles

T-DXd Shows Promise in Treating HER2+ Breast Cancer With Brain Mets

Nancy Lin, MD

September 24th 2024

Nancy Lin, MD, discusses the efficacy of T-DXd for brain metastases as seen in DESTINYBreast-12 compared with other agents.

Survival Advantage Observed in HER2+Breast Cancer With Brain Metastasis

Nancy Lin, MD

October 1st 2020

Nancy U. Lin, MD, discusses the results from a substudy of HER2CLIMB looking at tucatinib plus trastuzumab and capecitabine in patients with HER2-positive breast cancer and brain metastases.

HER2CLIMB Regimen Can Be Used Earlier in HER2+ Metastatic Breast Cancer

Nancy Lin, MD

September 16th 2020

Nancy U. Lin, MD, discusses how she would use the HER2CLIMB regimen of tucatinib plus trastuzumab and capecitabine now that it has been approved for treatment of patients with HER2-positive metastatic breast cancer.

HER2CLIMB Study Shows Efficacy in HER2 Breast Cancer With Brain Metastases

Nancy Lin, MD

July 1st 2020

Nancy U. Lin, MD, discusses the latest findings from the HER2CLIMB study of either tucatinib or placebo, added to trastuzumab and capecitabine, for patients with previously treated HER2-positive metastatic breast cancer who have brain metastases.

Systemic Therapies Shown to be Effective in HER2-Positive Breast Cancer

Nancy Lin, MD

April 20th 2020

Nancy Lin, MD, discusses options for patients with human epidermal growth factor receptor 2-positive breast cancer who also present with brain metastases.